Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Spengler

Showing results (151-160 of 224) with videos related to

Pageof 23
Sort By:
AIDS (London, England)|November 13, 2015
HIV mono-infection is associated with an impaired anti-hepatitis C virus activity of natural killer cellsFelix Goeser, Andreas Glässner, Pavlos Kokordelis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 16, 2005
Budesonide in previously untreated autoimmune hepatitisJohannes Wiegand, Andreas Schüler, Stephan Kanzler, et al.
Journal of Hepatology|April 30, 2013
Intrahepatic IL-8 producing Foxp3⁺CD4⁺ regulatory T cells and fibrogenesis in chronic hepatitis CBettina Langhans, Benjamin Krämer, Marcell Louis, et al.
Clinical and Translational Gastroenterology|May 31, 2023
IL-6-Dependent STAT3 Activation and Induction of Proinflammatory Cytokines in Primary Sclerosing CholangitisLeona Dold, Leonie Frank, Philipp Lutz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 29, 2021
A genetic variant in toll-like receptor 5 is linked to chemokine levels and hepatocellular carcinoma in steatohepatitisHans Dieter Nischalke, Janett Fischer, Alexandra Klüners, et al.
Plos One|June 9, 2017
Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART)Leona Dold, Carolin Luda, Carolynne Schwarze-Zander, et al.
Plos One|November 17, 2011
The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosisHans Dieter Nischalke, Cordula Berger, Carolin Luda, et al.
European Radiology|April 24, 2015
Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosisGuido M Kukuk, Kanishka Hittatiya, Alois M Sprinkart, et al.
Cancer Immunology, Immunotherapy : CII|November 15, 2019
Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinomaBettina Langhans, Hans Dieter Nischalke, Benjamin Krämer, et al.
Journal of Hepatology|September 20, 2020
A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCAGideon M Hirschfield, Ulrich Beuers, Limas Kupcinskas, et al.
Pageof 23

Showing results (151-160 of 224) with videos related to

Sort By:
Pageof 23
AIDS (London, England)|November 13, 2015
HIV mono-infection is associated with an impaired anti-hepatitis C virus activity of natural killer cellsFelix Goeser, Andreas Glässner, Pavlos Kokordelis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 16, 2005
Budesonide in previously untreated autoimmune hepatitisJohannes Wiegand, Andreas Schüler, Stephan Kanzler, et al.
Journal of Hepatology|April 30, 2013
Intrahepatic IL-8 producing Foxp3⁺CD4⁺ regulatory T cells and fibrogenesis in chronic hepatitis CBettina Langhans, Benjamin Krämer, Marcell Louis, et al.
Clinical and Translational Gastroenterology|May 31, 2023
IL-6-Dependent STAT3 Activation and Induction of Proinflammatory Cytokines in Primary Sclerosing CholangitisLeona Dold, Leonie Frank, Philipp Lutz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 29, 2021
A genetic variant in toll-like receptor 5 is linked to chemokine levels and hepatocellular carcinoma in steatohepatitisHans Dieter Nischalke, Janett Fischer, Alexandra Klüners, et al.
Plos One|June 9, 2017
Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART)Leona Dold, Carolin Luda, Carolynne Schwarze-Zander, et al.
Plos One|November 17, 2011
The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosisHans Dieter Nischalke, Cordula Berger, Carolin Luda, et al.
European Radiology|April 24, 2015
Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosisGuido M Kukuk, Kanishka Hittatiya, Alois M Sprinkart, et al.
Cancer Immunology, Immunotherapy : CII|November 15, 2019
Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinomaBettina Langhans, Hans Dieter Nischalke, Benjamin Krämer, et al.
Journal of Hepatology|September 20, 2020
A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCAGideon M Hirschfield, Ulrich Beuers, Limas Kupcinskas, et al.
Pageof 23